All News

The American Institute of Ultrasound in Medicine (AIUM) has granted ultrasound practice accreditation in urology to the Smith Institute for Urology of The North Shore LIJ Health System in New Hyde Park, NY.

Sacral neuromodulation produced efficacy and quality of life results that were superior to standard oral medication in what researchers say is the first study to compare the benefits of the two treatments in a population of less-severe overactive bladder patients.

Recovery from laparo-endoscopic single-site surgery (LESS) was less painful for kidney cancer patients than traditional laparoscopic surgery, according to a recent study by University of California, San Diego researchers.

Contrast-enhanced ultrasound was found to better detect high-grade prostate cancer than conventional methods, report researchers from Thomas Jefferson University and Hospitals, Philadelphia.

A one-time onabotulinumtoxinA (Botox) injection in the bladder worked as well as daily anticholinergic drugs for reducing episodes of urinary incontinence, and was more effective in completely resolving symptoms, according to a recent study.

The American College of Surgeons Board of Regents has presented urologist Jack W. McAninch, MD, with the College’s 2012 Distinguished Service Award.

AVEO Oncology has submitted a new drug application to the FDA seeking approval for tivozanib in patients with advanced renal cell carcinoma.

Two recent studies shed new light on the mechanism of maintaining an erection and genetic markers linked to erectile dysfunction after radiation therapy.

The AUA and the American Association of Clinical Urologists have announced a new agreement for UROPAC, the urology political action committee.

This special installment of "Hands On" is presented in a point-counterpoint format, with two leading experts discussing open versus. robot-assisted radical prostatectomy.

Participants in the American Association of Clinical Urologists' recent 5th Annual State Society Network Advocacy Conference took home valuable tools to improve their advocacy efforts and influence policymakers in their home state.

One-third of men with high-risk prostate cancer achieved pathologic complete response (pCR) or near-complete response to 6 months of preoperative therapy with abiraterone acetate (ZYTIGA), leuprolide, and prednisone, investigators reported at the American Society of Clinical Oncology annual meeting in Chicago.

Standard laparoscopic procedures are associated with more muscular contraction and trapezius muscle fatigue than robot-assisted approaches, according to a comparison of the two approaches conducted by 11 surgeons.

External application of pulsed electromagnetic fields using an investigational device (TranStim Transdermal Neuromodulation System, EMKinetics, Inc., Mountain View, CA) produces the same stimulation of the posterior tibial nerve as traditional electrical stimulation, results from a proof-of-concept study demonstrate.

High quantities of aberrantly expressed genes are predictive of tumor aggressiveness and poor oncologic outcomes in patients with clear cell renal cell carcinoma, according to a recent study.

The latest urology products and services from American Medical Systems and Covidien.

Older patients with early-stage kidney cancer had significant improvement in short-term survival after partial versus radical nephrectomy but no long-term survival benefit, data from a large retrospective study showed.

Zero-ischemia robotic partial nephrectomy appears to be feasible and safe, findings from a pilot study analyzing prospectively collected data in an institutional review board-approved database show.

Women taking atypical antipsychotic medications have about a threefold higher prevalence of lower urinary tract symptoms (LUTS) compared to nonusers, a recent study has found.

A study from Weill Cornell Medical College, New York suggests patients with metabolic syndrome may be at increased risk for clear cell renal cell carcinoma.

Salvage high-intensity focused ultrasound (HIFU) appears to be an effective treatment option for locally recurrent prostate cancer after primary external beam radiation therapy (EBRT), data from analyses of 6-year oncologic outcomes show.

The treatment benefit of intradetrusor onabotulinumtoxinA (Botox) for urinary incontinence due to neurogenic detrusor overactivity may decline after patients have received multiple repeat injections, findings from a study by Taiwanese urologists suggest.

With the presidential election looming, we thought it would be appropriate to look at the visions for health care reform put forth by the two presidential candidates, with an eye toward what a urology practice should do today to prepare for the future.

Adoption of robotic surgery for treatment of kidney cancer has led to a modest increase in the annual volume of partial nephrectomies but a substantial cost savings for care of chronic kidney disease, an economic analysis of a 6-year period suggests.

There is never a bad time to revisit the beneficiary designations you have made over the years.

While most of the urologists we interviewed use non-physician providers, they don't believe these practitioners are adequately trained to do cystoscopy.

Patients with early-stage kidney cancer fared much better with partial rather than radical nephrectomy if they were candidates for either procedure, say researchers from the University of Michigan, Ann Arbor.

Responders to the multi-targeted receptor tyrosine kinase inhibitor sunitinib (Sutent) have significantly longer progression-free survival and overall survival than non-responders, according to an analysis of 1,059 patients who participated in six clinical trials of sunitinib as first- or second-line therapy of metastatic renal cell carcinoma.